Vatché Bartekian,
With over 25 years of experience in the pharmaceutical and biotechnology sectors, Vatche Bartekian is the President and Founder of Vantage BioTrials, a leading Canadian CRO. He specializes in providing high-quality, cost-effective clinical trial management services across various therapeutic areas. Vatche’s extensive knowledge in drug development allows him to offer innovative solutions for clients in the pharmaceutical, biotech, and medical device industries. Vatche is deeply committed to advancing the life sciences sector and actively contributes as an advisor, speaker, and trainer. Throughout his career, he has received multiple accolades, including Emerging Pharma Leader and Biotechnology CRO of the Year, reflecting his leadership, entrepreneurship, and social responsibility. His mission is to continue growing Vantage BioTrials into a trusted partner for clinical research, positively impacting global health.
Vahé Bartekian,
Vice President, Quality Management
Since joining the CRO industry in 1993, Vahé continues to contribute his valuable knowledge of the clinical trials management process through his broad expertise in GCP/GCLP/GLP practices and procedures. Promoting the importance of quality and making it a core value of Vantage BioTrials, Vahé has played an integral role in introducing and implementing a Quality by Design and Risk Based Approach to Clinical Trial Management. The three essentials values that are of outmost importance to managing clinical trials are communication, quality and transparency and his dedication to these values remains paramount to the continued satisfaction of Vantage BioTrials’ Sponsors and the overall continued success of clinical trials.
Viken Bartekian,
Vice President, Corporate Development
With over 30 years of experience in the lifescience industry, Viken Bartekian is Vice President of Corporate Development and Co-Founder of Vantage BioTrials. Since joining Vantage BioTrials in 2007, Viken has played an integral role in the company’s growth and success. As part of his responsibilities, he oversees corporate and business development, general management, and marketing. His focus includes forecasting, planning, managing existing portfolios, identifying new business opportunities, and continuously implementing an integrated strategic marketing plan. Throughout his career, Viken has been committed to emphasizing the importance of risk mitigation strategies to ensure the successful and efficient execution of clinical studies. His leadership and forward-thinking approach have been essential in positioning Vantage BioTrials as a leading CRO in Canada, known for optimizing clinical research processes and improving trial outcomes.